Cranbury Pharmaceuticals DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Virtual Booth

Contact Supplier

Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Cranbury Pharmaceuticals operates as a wholly owned subsidiary of Tris Pharma Inc., an innovative biopharmaceutical company focused on pioneering differentiated approaches to improve therapeutic benefits and optimize patient outcomes. Tris Pharma specializes in addressing conditions such as attention-deficit/hyperactivity disorder (ADHD), pain management, addiction, and diseases affecting the central nervous system (CNS). By leveraging innovative research and development, Tris Pharma and its subsidiary Cranbury Pharmaceuticals aim to advance treatment options and provide effective solutions for patients in need.